Neurotech International Ltd has released a press release.
Quarterly Update & Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Neurotech International Ltd. on 6ix
Story so far
Earlier from Neurotech International
- Pause In Trading
- Quarterly Activities and Cashflow Report
- Response to ASX Price Query
- Dr Adrian Attard Trevisan
- Appendix 4D and 31 December 2018 Half Year Report
Later from Neurotech International
- Appendix 4E and Annual Report to Shareholders
- Cancellation of Mente Device from Australian TGA Register
- Response to Appendix 4C Query
- Mente receives CE Mark renewal for use with ASD Children
- NTI Secures Option to Cannabis Strains Targeting Autism
Follow Neurotech International into a list and get an email when it puts out news.
Follow Neurotech International